ClinicalNews

Keeping your hair on

bald baldness hiding man
Leading hair-loss treatment could be set to move to pharmacist-only category Regulators are set to decide on a request to down-schedule a leading hair-loss treatment to the S3 (Pharmacist Only) category. A proposal has been submitted for Finasteride (Propecia, from MSD, and its generic competitors) to be moved to S3, with the sponsor saying pharmacists

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous GP suspended over IGF-1
Next Location rules dispute continues

Related Posts